About Us

BCDD bridges academic innovation and early-stage drug discovery with cutting-edge research and industry-standard expertise

Photo: Chen Galili

The BLAVATNIK CENTER for Drug Discovery (BCDD) at Tel Aviv University was founded in 2015 by Prof. Ehud Gazit, who served as its founding director until 2025. Since May 2025, Prof. Asya Rolls has been serving as the center's academic director.

The BCDD is a leading research center for translational drug discovery, transforming academic innovations into promising drug candidates.

BCDD, Israel's leading center for academic drug discovery, combines medicinal chemistry, biological research, computational drug design, and metabolomics to accelerate the development of new drugs.

With advanced infrastructure and expertise, BCDD supports academic, industry, and hospital partners in advancing early-stage drug discovery into real-world therapeutic solutions.

Governance & Advisory Boards

BCDD is guided by two key advisory boards that shape its scientific direction and drive innovation.

The Academic Board - Led by the academic director and faculty representatives from Medicine, Life Sciences, Exact Sciences, and Engineering, ensuring a multidisciplinary approach.
The International Advisory Board - A panel of global experts in drug discovery who oversee research projects, evaluate scientific progress, and provide strategic guidance.

Driving Innovation in Drug Discovery: The BCDD Approach

Accelerated Drug Discovery - access a world-class research platform designed to streamline early-stage drug development and screening.
Rare Disease Focus - collaborate on translational research projects aimed at developing therapies for orphan diseases.
Personalized Medicine Approaches - leverage patient-derived, cell-based HTS platforms for precision drug development.
Metabolomics for Drug Discovery - utilize advanced metabolomics analysis to gain insights into drug mechanisms, biomarker discovery, and metabolic profiling.
Advanced Automation Technologies - implement high-throughput robotic screening and AI-driven drug discovery tools to enhance efficiency.
Seamless Transition from Research to Application - work with a center dedicated to bridging academy, industry, and hospitals to bring scientific breakthroughs to clinical and pharmaceutical applications.

BCDD provides academy, industry, and hospitals with the expertise, infrastructure, and innovative technology needed to develop disease models, biological assays, high-throughput screening tools, and metabolic profiling solutions, accelerating the path from discovery to drug development.

For collaboration opportunities or more information, contact us today.